| SpectraBase Spectrum ID |
226GYaXNVXh |
| Name |
1-(4-Chlorobenzyl)-4-(3,4-methylenedioxybenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
344.129155622 u |
| Formula |
C19H21ClN2O2 |
| InChI |
InChI=1S/C19H21ClN2O2/c20-17-4-1-15(2-5-17)12-21-7-9-22(10-8-21)13-16-3-6-18-19(11-16)24-14-23-18/h1-6,11H,7-10,12-14H2 |
| InChIKey |
TUQOIZSCSKHURN-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
344.842 g/mol |
| Nominal Mass |
344 u |
| Quality |
868 |
| Retention Index |
2758 |
| SMILES |
C1=2C(=CC=C(C2)CN2CCN(CC3=CC=C(C=C3)Cl)CC2)OCO1 |
| SPLASH |
splash10-004i-6910000000-644c8c869484d1984e22 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(4-chlorobenzyl)-4-(3,4-methylenedioxybenzyl)
1-(1,3-benzodioxol-5-ylmethyl)-4-(4-chlorobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011249 |
